Published in Eur J Surg Oncol on June 01, 2011
What is the problem in clinical application of sentinel node concept to gastric cancer surgery? J Gastric Cancer (2012) 1.06
Simultaneous mapping of pan and sentinel lymph nodes for real-time image-guided surgery. Theranostics (2014) 0.98
Endoscopic submucosal dissection for undifferentiated-type early gastric cancer: do we have enough data to support this? World J Gastroenterol (2014) 0.90
Endoscopic submucosal dissection and surgical treatment for gastrointestinal cancer. World J Gastrointest Endosc (2012) 0.89
The future of sentinel node oriented tailored approach in patients with early gastric cancer. J Gastric Cancer (2012) 0.86
Sentinel node navigation surgery for gastric cancer: Overview and perspective. World J Gastrointest Surg (2015) 0.83
Ever-changing endoscopic treatment for early gastric cancer: yesterday-today-tomorrow. World J Gastroenterol (2014) 0.79
Sentinel node navigation in gastric cancer: new horizons for personalized minimally invasive surgical oncology? Transl Gastroenterol Hepatol (2016) 0.77
How much progress has been made in minimally invasive surgery for gastric cancer in Korea?: a viewpoint from Korean prospective clinical trials. Medicine (Baltimore) (2014) 0.76
Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst (2000) 4.15
[Acute pancreatitis--a protocol for diagnosis and treatment]. Ned Tijdschr Geneeskd (2001) 3.91
Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer (2008) 2.62
Effect of adjuvant chemotherapy in postmenopausal patients with invasive ductal versus lobular breast cancer. Ann Oncol (2012) 2.06
On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands. Cancer Causes Control (2007) 1.93
Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer (2005) 1.93
Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol (2003) 1.69
Implementation of a short-stay programme after breast cancer surgery. Br J Surg (2010) 1.54
The introduction of mammographical screening has had little effect on the trend in breast-conserving surgery: a population-based study in Southeast Netherlands. Eur J Cancer (2001) 1.53
[Trends and variation in breast conserving surgery in the southeast and east of the Netherlands over the period 1990-2002]. Ned Tijdschr Geneeskd (2005) 1.50
Using loco-regional recurrence as an indicator of the quality of breast cancer treatment. Eur J Cancer (2004) 1.48
[Delirium after a fractured hip in more than one-third of the patients]. Ned Tijdschr Geneeskd (2007) 1.43
Presence of symptoms and timing of surgery do not affect the prognosis of patients with primary metastatic breast cancer. Eur J Surg Oncol (2011) 1.40
Predictors of recurrence of fulminant bacterial peritonitis after discontinuation of antibiotics in open management of the abdomen. Eur J Surg (1998) 1.40
Melanoma of the rectum: a rare entity. World J Gastroenterol (2008) 1.30
FDG-PET has no definite role in preoperative imaging in gastric cancer. Eur J Surg Oncol (2009) 1.28
Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer (2001) 1.19
Improving outcome for patients with pancreatic cancer through centralization. Br J Surg (2011) 1.19
Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram. Ann Surg Oncol (2009) 1.19
Economic evaluation of four follow-up strategies after curative treatment for breast cancer: results of an RCT. Eur J Cancer (2011) 1.18
A comparison of quality of life, disease impact and risk perception in women with invasive breast cancer and ductal carcinoma in situ. Eur J Cancer (2006) 1.17
Clinical epidemiology of breast cancer in the elderly. Eur J Cancer (2007) 1.17
Socioeconomic inequalities in attending the mass screening for breast cancer in the south of the Netherlands--associations with stage at diagnosis and survival. Breast Cancer Res Treat (2011) 1.16
Higher prevalence of sexual dysfunction in colon and rectal cancer survivors compared with the normative population: a population-based study. Eur J Cancer (2012) 1.14
Surgical resection of the primary tumour is associated with improved survival in patients with distant metastatic breast cancer at diagnosis. Eur J Surg Oncol (2009) 1.12
Interdigestive small bowel motility and duodenal bacterial overgrowth in experimental acute pancreatitis. Neurogastroenterol Motil (2003) 1.11
Internal mammary lymph drainage and sentinel node biopsy in breast cancer - A study on 1008 patients. Eur J Surg Oncol (2008) 1.11
Breast cancer in the southeastern Netherlands, 1960-1989: trends in incidence and mortality. Eur J Cancer (1993) 1.09
Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: a population-based study. Eur J Cancer (2006) 1.09
Age-specific differences in treatment and survival of patients with cervical cancer in the southeast of The Netherlands, 1986-1996. Eur J Cancer (2002) 1.06
Adherence to treatment guidelines and survival in patients with early-stage breast cancer by age at diagnosis. Br J Surg (2012) 1.06
Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer (2010) 1.06
Improved survival of patients with rectal cancer since 1980: a population-based study. Eur J Cancer (2003) 1.04
The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma. Eur J Surg Oncol (2005) 1.02
Impact of transition from analog screening mammography to digital screening mammography on screening outcome in The Netherlands: a population-based study. Ann Oncol (2012) 0.99
Margin status and the risk of local recurrence after breast-conserving treatment of lobular breast cancer. Breast Cancer Res Treat (2006) 0.99
The prognostic significance of axillary lymph-node micrometastases in breast cancer patients. Eur J Surg Oncol (2005) 0.99
Meta-analysis of predictive factors for non-sentinel lymph node metastases in breast cancer patients with a positive SLN. Eur J Surg Oncol (2011) 0.99
The role of ultrasound-guided lymph node biopsy in axillary staging of invasive breast cancer in the post-ACOSOG Z0011 trial era. Ann Surg Oncol (2014) 0.99
Local recurrence following breast-conserving treatment in women aged 40 years or younger: trends in risk and the impact on prognosis in a population-based cohort of 1143 patients. Eur J Cancer (2013) 0.98
Increased health care utilisation among 10-year breast cancer survivors. Support Care Cancer (2006) 0.97
Screening caused rising incidence rates of ductal carcinoma in situ of the breast. Breast Cancer Res Treat (2008) 0.97
Transanal endoscopic microsurgery for local excision of rectal lesions: is there a learning curve? Dig Surg (2009) 0.97
Improved survival of patients with primary distant metastatic breast cancer in the period of 1995-2008. A nationwide population-based study in the Netherlands. Breast Cancer Res Treat (2011) 0.94
Lymph node examination among patients with gastric cancer: variation between departments of pathology and prognostic impact of lymph node ratio. Eur J Surg Oncol (2011) 0.94
Nurse-led telephone follow-up and an educational group programme after breast cancer treatment: results of a 2 × 2 randomised controlled trial. Eur J Cancer (2011) 0.92
Risk factors for local recurrence after breast-conserving therapy for invasive carcinomas: a case-control study of histological factors and alterations in oncogene expression. Int J Radiat Oncol Biol Phys (1999) 0.91
No improvement in median survival for patients with metastatic gastric cancer despite increased use of chemotherapy. Ann Oncol (2013) 0.91
Colonic involvement in acute pancreatitis. A retrospective study of 16 patients. Dig Surg (2003) 0.91
Results of tailored treatment for breast cancer patients with internal mammary lymph node metastases. Breast (2009) 0.91
Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection. Eur J Surg Oncol (2006) 0.91
Prognostic factors for survival in metastatic breast cancer by hormone receptor status. Breast Cancer Res Treat (2014) 0.88
The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast. Eur J Surg Oncol (2007) 0.87
Stage migration due to introduction of the sentinel node procedure: a population-based study. Breast Cancer Res Treat (2008) 0.86
Assessment of the Memorial Sloan-Kettering Cancer Center nomogram to predict sentinel lymph node metastases in a Dutch breast cancer population. Eur J Cancer (2012) 0.86
Transanal endoscopic microsurgery for correction of rectourethral fistulae. J Endourol (2006) 0.85
Trends in surgery for screen-detected and interval breast cancers in a national screening programme. Br J Surg (2014) 0.85
Is current perioperative practice in hepatic surgery based on enhanced recovery after surgery (ERAS) principles? World J Surg (2014) 0.85
Resection of liver metastases in patients with breast cancer: survival and prognostic factors. Eur J Surg Oncol (2012) 0.85
Ex vivo sentinel lymph node "mapping" in colorectal cancer. Eur J Surg Oncol (2007) 0.84
A systematic review of the relation between interleukin-2 schedule and outcome in patients with metastatic renal cell cancer. Eur J Cancer (2004) 0.84
Bilothorax: a bitter complication of liver surgery. Case Rep Surg (2013) 0.84
Implementation of trastuzumab in conjunction with adjuvant chemotherapy in the treatment of non-metastatic breast cancer in the Netherlands. Breast Cancer Res Treat (2011) 0.83
Inferior survival for young patients with contralateral compared to unilateral breast cancer: a nationwide population-based study in the Netherlands. Breast Cancer Res Treat (2013) 0.83
Explanatory factors for variation in the use of breast conserving surgery and radiotherapy in the Netherlands, 1990-2001. Breast (2007) 0.83
Preoperative serum CA125 levels do not predict suboptimal cytoreductive surgery in epithelial ovarian cancer. Int J Gynecol Cancer (2007) 0.83
Prevalence of lymphoedema more than five years after breast cancer treatment. Eur J Surg Oncol (2011) 0.83
The diagnostic value of one-step nucleic acid amplification (OSNA) for sentinel lymph nodes in colon cancer patients. Ann Surg Oncol (2014) 0.82
Reliability of receptor assessment on core needle biopsy in breast cancer patients. Tumour Biol (2012) 0.82
Prognosis following local recurrence after breast conserving treatment in young women with early breast cancer. Eur J Surg Oncol (2013) 0.82
Follow-up after curative treatment for breast cancer: why do we still adhere to frequent outpatient clinic visits? Eur J Cancer (2007) 0.82
[Breast cancer in young women: epidemiology and treatment dilemmas]. Ned Tijdschr Geneeskd (2008) 0.82
The influence of tamoxifen treatment on the oestrogen receptor in metachronous contralateral breast cancer. Br J Cancer (2003) 0.82
Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer. Br J Cancer (2012) 0.82
Patients with invasive lobular breast cancer are less likely to undergo breast-conserving surgery: a population based study in the Netherlands. Ann Surg Oncol (2014) 0.82
ARM: axillary reverse mapping - the need for selection of patients. Eur J Surg Oncol (2012) 0.81
Changes in treatment patterns and their influence on long-term survival in patients with stages I-III gastric cancer in The Netherlands. Int J Cancer (2013) 0.81
Small but significant socioeconomic inequalities in axillary staging and treatment of breast cancer in the Netherlands. Br J Cancer (2012) 0.80
DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients. Endocr Relat Cancer (2007) 0.80
Variations in screening outcome among pairs of screening radiologists at non-blinded double reading of screening mammograms: a population-based study. Eur Radiol (2014) 0.79
Outcome of colonic surgery in elderly patients with colon cancer. J Oncol (2010) 0.79
Inconsistent selection and definition of local and regional endpoints in breast cancer research. Br J Surg (2014) 0.79
Lymphatic mapping after previous breast surgery. Breast (2011) 0.78
Results of construction of protective loop ileostomies and reversal surgery for colorectal surgery. Eur Surg Res (2014) 0.78
Effectiveness of routine follow-up in the detection of contralateral breast cancer in young women with early breast cancer. Eur J Surg Oncol (2013) 0.78
Micro-metastases in stages I and II colon cancer are a predictor of the development of distant metastases and worse disease-free survival. Eur J Surg Oncol (2008) 0.78
Explaining variations in survival in breast cancer in the Eastern Region of England. Ann Oncol (2009) 0.78
Detection, treatment and outcome of axillary recurrence after axillary clearance for invasive breast cancer. Br J Surg (2001) 0.78
Epidural analgesia associated with better survival in colon cancer. Int J Colorectal Dis (2015) 0.78
Re-attendance after false-positive screening mammography: a population-based study in the Netherlands. Br J Cancer (2013) 0.77
Staging and management of axillary lymph nodes in patients with local recurrence in the breast or chest wall after a previous negative sentinel node procedure. Eur J Surg Oncol (2010) 0.77
The number of high-risk factors is related to outcome in stage II colonic cancer patients. Eur J Surg Oncol (2011) 0.77
Value of Memorial Sloan-Kettering Cancer Center nomogram in clinical decision making for sentinel lymph node-positive breast cancer. Br J Surg (2010) 0.77
Family history of breast cancer and local recurrence after breast-conserving therapy. The Dutch Study Group on Local Recurrence after Breast Conservation (BORST). Eur J Cancer (1999) 0.77